Xencor | Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
AbbVie USD -3.27B 628M 2025-12
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
Amgen USD 8.66B 961M 2025-12
Arrowhead Research USD 568.42M 102.37M 2025-12
AstraZeneca USD 48.67B 2.78B 2025-12
Biogen USD 18.21B 573.5M 2025-09
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Cytokinetics USD -659.62M 138.5M 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
J&J USD 78.47B 0 2025-09
Karyopharm Therapeutics USD -269.26M 30.33M 2025-09
MacroGenics USD 67M 20.38M 2025-09
Merck USD 51.85B 2.79B 2025-09
Novartis USD 44.75B 2.7B 2025-09
Pfizer USD 92.8B 4.11B 2025-09
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Xencor USD 635.59M 10.27M 2025-12


Xencor Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.